Spotify founder Daniel Ek is making waves in the health tech industry with his company, Neko Health. Founded in 2018 with Hjalmar Nilsonne, Neko Health aims to revolutionize preventative healthcare through advanced body scanning technology and AI-powered analysis. The company's vision is to create a healthcare system that proactively helps people stay healthy via preventative measures and early detection of potential issues.
Neko Health's core offering is a non-invasive full-body scan that utilizes over 70 sensors to collect approximately 50 million data points in just minutes. The scan employs a combination of technologies, including high-resolution 2D and 3D photography, thermal imaging, and detailed cardiovascular measurements. This comprehensive approach allows Neko Health to map the body both inside and out, checking for a wide range of health indicators.
The Neko Health Scan checks for moles and marks across the body, symptoms of metabolic syndrome, and risk factors for stroke and heart attack, along with blood sugar levels to assess pre-diabetes risk. It can detect skin changes as small as 0.2 millimeters and identify early warning signs across the body's major systems, including cardiovascular issues, metabolic changes, inflammatory markers, and early indicators of eye pressure problems.
After the 10-minute scan is complete, artificial intelligence (AI) analyzes the collected data and provides users with a detailed picture of their health status in under an hour. This allows individuals to gain insights into potential health fallibilities and take preventative measures to improve their health. A doctor-led consultation follows the scan, providing members with full results and personalized recommendations.
Neko Health's commitment to preventative care has resonated with consumers. Since launching its first body scanning facility in Stockholm in early 2023, and later expanding to London in September 2024, the company has completed over 10,000 scans. Impressively, about 80% of members book and prepay for a scan for the following year at the end of their appointment, demonstrating the value they place on this proactive approach to healthcare. The company currently has a waiting list of over 100,000 people.
To support its mission, Neko Health has secured significant funding. In January 2025, the company announced the completion of a $260 million Series B funding round led by Lightspeed Venture Partners, with participation from General Catalyst, O.G. Venture Partners, Rosello, Lakestar, and Atomico. This latest funding brings Neko Health's valuation to $1.7 billion. Prior to this, Neko Health raised $65 million in a Series A funding round in July 2023. The funding is being used to accelerate the company's expansion plans in Europe and the US, as well as to invest in R&D for new breakthrough health diagnostics. The company plans to open more clinics and continue to bring innovations to the market to find and prevent disease before it has a chance to develop.
Neko Health's entry into the health tech space signifies a growing trend towards proactive and personalized healthcare. By combining advanced sensor technology with AI-powered analysis, Neko Health is empowering individuals to take control of their health and well-being.
